Loading…

Management of the sensitized adult heart transplant candidate

Eckman PM, Hanna M, Taylor DO, Starling RC, Gonzalez‐Stawinski GV. Management of the sensitized adult heart transplant candidate. 
Clin Transplant 2010: 24: 726–734. © 2010 John Wiley & Sons A/S. :  Heart transplant recipients sensitized to human leukocyte antigens comprise a challenging subgrou...

Full description

Saved in:
Bibliographic Details
Published in:Clinical transplantation 2010-11, Vol.24 (6), p.726-734
Main Authors: Eckman, Peter M., Hanna, Mazen, Taylor, David O., Starling, Randall C., Gonzalez-Stawinski, Gonzalo V.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Eckman PM, Hanna M, Taylor DO, Starling RC, Gonzalez‐Stawinski GV. Management of the sensitized adult heart transplant candidate. 
Clin Transplant 2010: 24: 726–734. © 2010 John Wiley & Sons A/S. :  Heart transplant recipients sensitized to human leukocyte antigens comprise a challenging subgroup of patients. Sensitization has been associated with a variety of effects that determine short‐term and long‐term outcomes. These include a higher rate of acute rejection and graft loss, and a heightened risk for developing cardiac allograft vasculopathy. Because of improvements in both tissue typing and immunomodulatory therapies coupled with the growing population receiving mechanical circulatory support/LVAD, the percent of sensitized patients listed for heart transplantation has increased, inflicting a greater burden to the already scarce donor pool. Despite these potentially adverse developments, pre‐transplant immunologic management has resulted in decreased waiting times and outcomes that were not possible over 10 yr ago. The following review will focus on the contemporary management of the sensitized heart transplant candidate and highlight therapies that have allowed the successful transplantation of this growing and challenging patient population, including several approaches in development.
ISSN:0902-0063
1399-0012
DOI:10.1111/j.1399-0012.2010.01259.x